• Tetraethylammonium Chloride: From Block to Biology

  2026-08-21

  Tetraethylammonium chloride is more than a potassium-channel blocker: it is a mechanistic probe for connecting pore conduction with vascular, ganglionic, and cellular phenotypes. This article integrates TEAC with orthogonal assay logic from classic β-cell research to improve interpretation and experimental design.

• ONX-0914: A Mechanism-First Assay Guide

  2026-08-20

  ONX-0914 (PR-957) is a selective LMP7 inhibitor that helps separate immunoproteasome biology from broad proteasome stress. This guide connects its autoimmune research applications with interferon-licensed antiviral assays and practical experimental decisions.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-20

  Breen and colleagues developed a drug-sensitized Saccharomyces cerevisiae platform that substantially improves detection of TOR pathway inhibitors compared with a wild-type yeast background. The system distinguishes TOR1-dependent growth inhibition and identified activity for established inhibitors and aminophylline, while finding no evidence of TOR inhibition by several test compounds, including Canagliflozin.

• GDC-0941 PI3K Inhibitor: Applied Research Guide

  2026-08-19

  GDC-0941 provides a practical way to interrogate PI3K/Akt signaling, from rapid pAKT suppression to cancer cell proliferation inhibition and resistance-model studies. This guide translates pathway biology and a recent pancreatic cancer study into reproducible workflows, assay pairings, and troubleshooting decisions.

• O-propargyl-puromycin (OPP) in B-Cell Translation

  2026-08-19

  O-propargyl-puromycin (OPP) converts nascent protein production into a measurable chemical signal. This article explains how to use that readout to interpret the Pcbp1–mitochondrial translation axis in B-cell immunity without confusing global synthesis with protein-specific function.

• Polyethylenimine Linear: PEI MW 40,000 Workflows

  2026-08-18

  Build serum-compatible DNA delivery workflows for transient gene expression, functional genomics, and recombinant protein production with a scalable linear polymer. The article also shows how to adapt PEI-based plasmid assays to investigate the H3K18la–NOD2 pathway described in bilirubin-injured astrocytes, while separating published evidence from practical optimization.

• Ciprofloxacin Research Workflows

  2026-08-18

  Discover how Ciprofloxacin supports both classical antimicrobial resistance research and emerging ultrasound-guided nanotheranostic assays. This workflow-focused guide translates a 2026 ZIF8 study into practical formulation, cell-based, release, and troubleshooting strategies.

• Marein Restores Mitoxantrone Sensitivity via ABCG2

  2026-08-17

  The reference study identifies marein, a chalcone glycoside from Coreopsis tinctoria Nutt, as a competitive inhibitor of ABCG2-mediated drug efflux. By increasing intracellular exposure to ABCG2 substrates, including Mitoxantrone, marein restored drug sensitivity in resistant cancer-cell models and linked this activity to interaction with the conserved F439 residue.

• Annexin V-PE Apoptosis Detection Kit Guide

  2026-08-17

  A scenario-driven guide to selecting, staining, and interpreting the Annexin V-PE Apoptosis Detection Kit (SKU K2200) in cytotoxicity, viability, and inflammation-related experiments. It connects phosphatidylserine biology with practical flow cytometry and microscopy workflows while highlighting controls, limitations, and reproducibility considerations.

• EdU Flow Cytometry Assay Kits (Cy5) Workflow

  2026-08-16

  Build a denaturation-free flow cytometry cell proliferation assay around direct S-phase DNA synthesis measurement. This guide connects the EdU Flow Cytometry Assay Kits (Cy5) to epithelial wound-healing models, pharmacodynamic studies, genotoxicity testing, and cancer research cell proliferation while emphasizing controls, gating, and troubleshooting.

• Ruxolitinib (INCB018424) Assay Guide

  2026-08-15

  A scenario-based laboratory guide to using Ruxolitinib (INCB018424), SKU A3012, in viability, proliferation, and cytotoxicity workflows. It connects JAK1/2 potency, solubility, dose-response design, interpretation, and vendor selection to practical assay reproducibility.

• Myriocin Workflows for SPT Research

  2026-08-15

  Myriocin enables controlled inhibition of the rate-limiting step in de novo sphingolipid synthesis, helping researchers connect ceramide changes with apoptosis, proliferation, and immune phenotypes. This practical workflow adapts evidence from cardiac remodeling research to cell-based assay design, with dose planning, orthogonal validation, and troubleshooting guidance.

• Angiotensin II: Workflows for Vascular Research

  2026-08-14

  Build reproducible Angiotensin II assays for macrophage inflammation, vascular smooth muscle cell hypertrophy research, and cardiovascular remodeling investigation. This practical guide connects receptor-proximal signaling with the Cx43/NF-κB findings of a macrophage study and provides preparation, dosing, and troubleshooting guidance.

• N6-Methyl-dATP for Fidelity Assays

  2026-08-14

  N6-Methyl-dATP gives researchers a controlled way to test how adenine methylation changes polymerase recognition, incorporation, and downstream DNA readouts. This workflow connects biochemical fidelity measurements with AML mechanism studies while clearly separating validated reference findings from exploratory assay applications.

• HyperScribe SP6 Kit for RNA Assay Design

  2026-08-13

  The HyperScribe SP6 High Yield RNA Synthesis Kit supports controlled RNA production for mechanistic studies of viral immune evasion. This article translates the SARS-CoV-2 N–GADD34 finding into a practical framework for RNA design, labeling, controls, and assay interpretation.

449 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page